Date:3/5/2010

ccrued expenses and other payables 2,853 19,472 19,269 Deferred revenue 5,135 35,049 18,351 Amounts due to related parties 384 2,621 -- Income tax payable 584 3,989 4,321 Total current liabilities 16,822 114,824 47,069 Deferred revenue 12,530 85,530 74,231 Other non-current liabilities 2,113 14,427 13,551 Deferred tax liabilities 414 2,827 4,017 Total liabilities 31,879 217,608 138,868 Commitments and contingencies Redeemable ordinary shares of China Cord Blood Services Corporation US$0.0001 par value, 14,614,140 shares issued and outstanding as of March 31, 2009 (redemption value of US$51,088,745 as of March 31, 2009) -- -- 386,577 EQUITY China Cord Blood Corporation shareholders' equity Ordinary shares US$0.0001 par value, 250,000,000 shares authorized, 43,237,100 shares and 66,182,726 shares issued and outstanding as of March 31, 2009 and December 31, 2009, respectively 7 45 34 Additional paid-in capital 102,233 697,834 140,745 Accumulated other comprehensive loss 2,055 14,023 (19,319) Retained earnings 10,425 71,161 44,082 Total China Cord Blood Corporation shareholders' equity 114,720 783,063 165,542 Noncontrolling interests 1,357 9,265 5,404 Total equity 116,077 792,328 170,946 Total liabilities, redeemable ordinary shares and equity 147,956 1,009,936 696,391 Exhibit 2 CHINA
'/>"/>

SOURCE China Cord Blood Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
2. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
3. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
4. China Medical Technologies Reports Third Fiscal Quarter Financial Results
5. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
6. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
7. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
8. China Sky One Medical Confirms Continued Sale of Seven of Eight Products on the Ministry of Healths Warning List
9. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
10. China Medical Technologies to Participate Investor Conferences in March 2010
11. China Biologic Products Responds to Allegations on Financial Websites